E R Kisanga

Summary

Affiliation: University of Bergen
Country: Norway

Publications

  1. ncbi request reprint Tamoxifen administration and metabolism in nude mice and nude rats
    E R Kisanga
    The Hormone Laboratory, Department of Clinical Biochemistry, Haukeland University Hospital, University of Bergen, Norway
    J Steroid Biochem Mol Biol 84:361-7. 2003
  2. ncbi request reprint Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial
    Elton R Kisanga
    Hormone Laboratory, Haukeland University Hospital, Department of Medicine, and Centre for International Health, University of Bergen, Bergen, Norway
    Clin Cancer Res 10:2336-43. 2004
  3. ncbi request reprint Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism
    J Gjerde
    The Hormone Laboratory, Haukeland University Hospital, N 5021 Bergen
    Ann Oncol 19:56-61. 2008
  4. ncbi request reprint Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry
    J Gjerde
    Hormone Laboratory, Haukeland University Hospital, N 5021 Bergen, Norway
    J Chromatogr A 1082:6-14. 2005
  5. ncbi request reprint A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers
    Andrea Decensi
    Division of Chemoprevention, European Institute of Oncology, and University of Milan School of Medicine, Milan, Italy
    J Natl Cancer Inst 95:779-90. 2003
  6. ncbi request reprint Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats
    Jan Schjøtt
    Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, N 5021 Bergen, Norway
    Basic Clin Pharmacol Toxicol 98:231-4. 2006

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Tamoxifen administration and metabolism in nude mice and nude rats
    E R Kisanga
    The Hormone Laboratory, Department of Clinical Biochemistry, Haukeland University Hospital, University of Bergen, Norway
    J Steroid Biochem Mol Biol 84:361-7. 2003
    ..c. pellet implants...
  2. ncbi request reprint Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial
    Elton R Kisanga
    Hormone Laboratory, Haukeland University Hospital, Department of Medicine, and Centre for International Health, University of Bergen, Bergen, Norway
    Clin Cancer Res 10:2336-43. 2004
    ..Furthermore we studied tamoxifen effects on the cancer proliferation marker Ki-67, and on sex hormone-binding globulin (SHBG)...
  3. ncbi request reprint Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism
    J Gjerde
    The Hormone Laboratory, Haukeland University Hospital, N 5021 Bergen
    Ann Oncol 19:56-61. 2008
    ..Therefore, we examined the relationship between CYP2D6 genotype, SULT1A1 genotype, SULT1A1 copy number and the pharmacokinetics of tamoxifen...
  4. ncbi request reprint Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry
    J Gjerde
    Hormone Laboratory, Haukeland University Hospital, N 5021 Bergen, Norway
    J Chromatogr A 1082:6-14. 2005
    ..The lower limits of quantification were 0.25 ng/mL for 4OHtam, NDtam and tam, 1.0 ng/mL for NDDtam and tamNox. Ranges of within- and between-day variation were 2.9-15.4% and 4.4-12.9%, respectively...
  5. ncbi request reprint A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers
    Andrea Decensi
    Division of Chemoprevention, European Institute of Oncology, and University of Milan School of Medicine, Milan, Italy
    J Natl Cancer Inst 95:779-90. 2003
    ....
  6. ncbi request reprint Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats
    Jan Schjøtt
    Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, N 5021 Bergen, Norway
    Basic Clin Pharmacol Toxicol 98:231-4. 2006